"Product (Company, therapeutic area)",NPV in billion U.S. dollars
"Tirzepatide (Eli Lilly, diabetes)",12.7
"Lirentelimab (Allakos, inflammatory)",8.2
"SRP-9001 (Sarepta, muscular)",6.3
"Deucravacitinib (BMS, autoimmune)",6.0
"LN-144 (Iovance, cancer)",5.3
"Sotorasib (Amgen, lung cancer)",4.7
"Bempegaldesleukin (Nektar, cancer)",4.3
"Tezepelumab (Amgen/Astrazeneca, asthma)",4.1
"Amivantamab (J&J/Genmab, lung cancer)",3.1
"CTX001 (Vertex/CRISPR, sickle cell)",3.0
